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Synaptophysin is a major integral membrane protein of synaptic vesicles. Its transmembrane topology deduced from the cDNA sequence predicts 
4 transmembrane r gions and a carboxy-terminal cytoplasmic tail containing a characteristic pentapeptide repeat structure. The monoclonal anti- 
body (mAb), SY38, binds to a cytoplasmic domain of synaptophysin. By using fusion proteins corresponding to truncated forms of the cytoplasmic 
tail, its epitope was Located to a flexible segment in the center of the repeat structure. Four other mAbs (~7.1, ~7.2, ~7.3, ~7.4) share the same 
epitope, which thus emerges as the major immunogenic region of this membrane protein. 
Synaptophysin; Synaptic vesicle; Antigenic epitope; Site-directed mutagenesis; (Rat brain) 
1. INTRODUCTION 
Synaptic vesicles are organelles specialized for 
packaging, storing and releasing neurotransmitters. In 
pres~aptic terminals different populations of these 
vesicles are found which differ in size and contents. 
Synaptophysin is a hexameric glycosylated protein of 
h4, 38000 which is localized in small clear vesicles 
(40-60 nm diameter) [1,2]. Its primary structure has 
been determined from cloned cDNA [3,4]. The 
pol~eptide is predicted to span the membrane 4-times 
and has a long cytoplasmic tail with a novel type of 
repeat structure (fig.1). This transmembrane topology 
is supported by protease digestion and antibody bin- 
ding data [3,5,6] and resembles that of connexins which 
form transmembrane channels allowing cellular coupl- 
ing via gap junction structures. After incorporation in- 
to planar lipid bilayers, synaptophysin displays 
voltage-sensitive channel activity [7]. This membrane 
protein therefore is thought to mediate translocation of 
vesicular contents during packaging and/or release of 
neurotransmitter. 
Synaptophysin was initially identified and localized 
by using a monoclonal antibody (mAb), SY38, which 
resulted from immunization with coated vesicles of 
bovine brain tissue [l]. Immunogold labelling showed 
that this antibody binds to a cytoplasmic domain of the 
membrane protein. Here, we have localized the epitope 
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of mAb SY38 by using fusion proteins covering 
variable portions of the cytoplasmic tail region. Our 
data define a dominant immunogenic determinant of 
this abundant vesicle channel protein. 
2. MATERIALS AND METHODS 
2.1. Fusion constructs 
To isolate the cDNA sequence corresponding to the C-terminal 
cytoplasmic tail of synaptophysin, an artificial EcoRI restriction site 
was introduced by site-directed mutagenesis after tr~smembr~e 
region 4 ffig.1). The resulting EcoRI fragment, called SCY (synap- 
tophysin cytoplasmic tail), was subcloned into the expression vector 
pEX34b [8]. 
The SCY fragment was also cloned into Ml3mp18 and used as a 
template for introducing stop codons (TAG) at 4 different positions 
by the method of Sayers et al. [9]. The resulting mutants (see fig.1) 
were recloned into pEX34b. All constructs were confirmed by DNA 
sequencing [lo]. 
2.2. Expression of fusion proteins 
Expression of fusion proteins in E. coli (Pop 2136) was induced by 
a 2 h incubation at 42”C, a condition which inactivates the 
temperature-sensitive c&repressor of this strain [8]. Bacteria then 
were collected by centrifugation and solubilized in SDS sample buffer 
1111. 
2.3. Electrophoresis and immunoblotting 
SDS-polyacrylamide lectrophoresis (SDS-PAGE) was performed 
according to Laemmli [ll], and Western blotting using the method 
of Towbin et al. [12]. Polyclonal antibodies were visualized using 
~kaline-phosphatase conjugated anti-rabbit IgG (Promega), and 
mon~lon~ antibodies using alkaline phosphatase conjugated anti- 
mouse IgG (Promega). 
3. RESULTS AND DISCUSSION 
After introduction of an artificial EcoRI site, a frag- 
ment of the synaptophysin cDNA encoding the 
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Fig. 1. Construction of truncated MS2-SCY fusion proteins. An EcoRI site was introduced in the synaptophysin cDNA after the transmembrane 
regions (Ml-M4; hatched boxes), and the SCY-fragment then subcloned into pEX34 to obtain a fusion construct with MS2 polymerase. Stop- 
codons introduced by oligonucleotide-directed mutagenesis are indicated by arrows. Pentapeptide repeats are overlined by bars; a thin bar 
indicates the degenerate repeat of the SY38 epitope. For amino acid numbering, see [3]. 
cytoplasmic tail region was subcloned into the expres- 
sion vector pEX34. The resulting MS2 polymerase fu- 
sion protein (SCY-MS2) was recognized in Western 
blots by both the mAb SY38 [l] and a polyclonal an- 
tiserum raised against a purified synaptophysin 
preparation [3] (see fig.2, lane 5). 
To obtain truncated forms of the cytoplasmic tail of 
synaptophysin, the SCY insert was cloned into 
M13mp18, and the single-stranded DNA was used as a 
template for site-directed mutagenesis. TAG stop 
codons were created at 4 different positions as in- 
dicated in fig. 1, and the mutated inserts recloned into 
pEX34. 
After transformation of E. cofi strain Pop 2136, the 
fusion proteins produced upon induction were analyzed 
by Western blotting (fig.2). As the Pop strain is a C600 
derivative of supF genotype, all transformants produc- 
ed some wild-type sized SCY-MS2 fusion protein 
resulting from read-through in addition to the trun- 
cated version. In immunoblots all St-mutants were 
recognized by a polyclonal synaptophysin antiserum, 
1 2 3 4 5 6 7 9 9 
-66 
-45 
-36 
.s, - 20.1 
-14.2 
-SY 38-pAb_ 
Fig.2. Western blot analysis of fusion proteins. Fusion proteins were 
expressed in E. coli after transfection with the various pEX34 
constructs, electrophoresed on 10% SDS-PAGE and analyzed by 
Western blotting using either mAb SY38 (left) or a polyclonal 
antibody against synaptophysin (right). (Lanes 1 and 9) St4-MS2 
construct; (lanes 2 and 8) St3-MS2 construct; (lanes 3 and 7) St2-MS2 
construct; (lanes 4 and 6) Stl-MS2 construct; (lanes 5 - both sides) 
Fig.3. Western blot analysis of fusion proteins using mAb ~7.4. For 
experimental details, see legend to fig.2. The following protein 
samples were applied: (lane 1) St4-MS2 construct; (lane 2) St3-MS2 
construct; (lane 3) St2-MS2 construct; (lane 4) Stl-MS2 construct; 
(lane 5) SCY-MS2 fusion protein; (lane 6) purified synaptophysin 
(500 ng). An identical picture was also obtained with mAbs ~7.1, ~7.2 
SCY-MS2 fusion protein. and ~7.3 (not shown). 
while the mAb SY38 bound only to Stl-MS2 and 
St2-MS2 fusion proteins but not to the shorter versions 
St3-MS2 and St4-MS2. The wild-type size proteins ex- 
pressed from these DNAs have only a single amino acid 
exchange due to supF action. Indeed, they were all 
recognized by the mAb except for St3-MS2. Thus, the 
tyrosine residue at position 269 is located within the 
SY38 epitope (fig.2). 
Four other independently isolated mAbs against 
synaptophysin, c7.1-~7.4, were also tested; the same 
result was obtained with all these antibodies (illustrated 
for mAb ~7.4 in fig.3). Thus, the region between Tyr 
269 and Tyr 289 defines a major immunogenic epitope 
of synaptophysin. 
The repeat structure of SCY contains ten copies of an 
imperfect pentapeptide repeat (YGP(Q)QG; see fig. 1). 
The most degenerate repeat, i.e. the region between Ser 
278 and Tyr 283, coincides with the monoclonal an- 
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tibody epitope. Flexible segments are considered highly 
immunogenic regions of proteins. Interestingly, by 
computer analysis the sequence (Pro-Ala-Ser-Gly-Gly- 
Gly-Gly) is predicted to belong to the most flexible 
regions in synaptophysin. We therefore believe that the 
repeat domain of the cytoplasmic tail forms a rigid 
structure interrupted by a highly immunogenic flexible 
segment, which represents a major portion of the SY38 
epitope. In addition, Tyr 269 must be important as its 
replacement destroyed antibody binding. 
Torpedo synaptophysin [13] exhibits 62% amino 
acid identity to the rat protein; its cytoplasmic region, 
however, is highly diverged and not recognized by an- 
tibodies specific for the epitope defined here [ 131. Se- 
quence comparison indeed reveals marked sequence 
differences in this region: 
st3 st2 
(269) (289) 
II II 
Torpedo: YQPNYGQQEYPPQGG----DYQ 
II II II II II II II II II II 
Rat: YQPDYGQPASGGGGYGPQGDYG 
Thus, the antigenic domain of the mammalian protein 
most likely is not crucial to the channel function of this 
transmembrane protein. 
The localization of the SY38 epitope presented here 
may be helpful for elucidating the effects of this an- 
tibody in functional assays. Interestingly, addition of 
SY38 mAb to synaptophysin reconstituted into planar 
lipid bilayer alters its channel properties [7]. Thus, the 
repeat structure of SCY may be implicated in confor- 
mational changes accompanying channel activation. 
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